Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · May 03, 2022

Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes

The Journal of Clinical Endocrinology and Metabolism


Additional Info

The Journal of Clinical Endocrinology and Metabolism
Prolonged use of proton pump inhibitors and risk of type 2 diabetes: results from a large population-based nested case-control study
J. Clin. Endocrinol. Metab. 2022 Apr 16;[EPub Ahead of Print], S Ciardullo, F Rea, L Savaré, G Morabito, G Perseghin, G Corrao

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading